MATE inhibitors
DBCAT003957Pharmacologic class
Includes Multidrug and toxin extrusion protein 1 and Multidrug and toxin extrusion protein 2 inhibitors. A DrugBank category of 91 drugs. 87 of them are approved.
What you can answer from here — as of October 10, 2018
Which targets do MATE inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account